599 filings
Page 5 of 30
424B2
rrhtam99 pcpzp6
8 Mar 21
Prospectus for primary offering
5:00pm
CORRESP
pr2vt8
5 Mar 21
Correspondence with SEC
12:00am
CORRESP
h7gmt
5 Mar 21
Correspondence with SEC
12:00am
6-K
sb9y2yr8f
4 Mar 21
Current report (foreign)
8:09am
UPLOAD
tm1uqy3
4 Mar 21
Letter from SEC
12:00am
6-K
wxv c8jqnqr0uch8jk8
2 Mar 21
Portage Announces Filing of Third Quarter Financial Statements
8:13am
6-K
v5l 6t2ozb71
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
6-K
wr9pbjcm
25 Feb 21
Current report (foreign)
8:11am
F-3
uxb913
24 Feb 21
Shelf registration (foreign)
5:22pm
CERT
wsii 7mc9
24 Feb 21
Certification of approval for exchange listing
5:04pm
8-A12B
y57sbo5c8t
18 Feb 21
Registration of securities on exchange
12:46pm
6-K
7mf16hzgvk6nq6g
11 Feb 21
Portage Biotech Provides Research and Development Update and Announces Nasdaq Listing Approval
4:30pm
6-K
5kl9hbv77wo4
1 Dec 20
Condensed Consolidated Interim Financial Statements
7:13am
6-K
gmmfnd
16 Oct 20
Portage Announces Filing of Q1 Interim Financial Statements; Correction to Salvarx Loan Note Settlement Announcement
4:12pm
6-K
lakfrqfw5e2 rwqk1zn
16 Oct 20
Consolidated Interim Financial Statements
2:44pm
6-K
ci06d2y wh3
13 Oct 20
Portage Issues Common Shares and Warrants In Settlement of Salvarx Loan Note Obligations
10:15am
NT 20-F
ai1ldclmql
31 Jul 20
Notice of late annual filing (foreign)
2:51pm
6-K
erut6ie ht
30 Jun 20
Report of Foreign Private Issuer
1:11pm
6-K
ewc4fcis itqe
17 Jun 20
Report of Foreign Private Issuer
10:46am